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Abstract
Polymicrobial biofilms are an understudied and a clinically relevant problem. This study
evaluates the interaction between C. albicans, and methicillin- susceptible (MSSA) and re-
sistant (MRSA) S. aureus growing in single- and dual-species biofilms. Single and dual spe-
cies adhesion (90 min) and biofilms (12, 24, and 48 h) were evaluated by complementary
methods: counting colony-forming units (CFU mL-1), XTT-reduction, and crystal violet stain-
ing (CV). The secretion of hydrolytic enzymes by the 48 h biofilms was also evaluated using
fluorimetric kits. Scanning electron microscopy (SEM) was used to assess biofilm structure.
The results from quantification assays were compared using two-way ANOVAs with Tukey
post-hoc tests, while data from enzymatic activities were analyzed by one-wayWelch-
ANOVA followed by Games-Howell post hoc test (α = 0.05). C. albicans, MSSA and MRSA
were able to adhere and to form biofilm in both single or mixed cultures. In general, all micro-
organisms in both growth conditions showed a gradual increase in the number of cells and
metabolic activity over time, reaching peak values between 12 h and 48 h (ρ<0.05). C. albi-
cans single- and dual-biofilms had significantly higher total biomass values (ρ<0.05) than
single biofilms of bacteria. Except for single MRSA biofilms, all microorganisms in both
growth conditions secreted proteinase and phospholipase-C. SEM images revealed exten-
sive adherence of bacteria to hyphal elements of C. albicans. C. albicans, MSSA, and
MRSA can co-exist in biofilms without antagonism and in an apparent synergistic effect,
with bacteria cells preferentially associated to C. albicans hyphal forms.
Introduction
Biofilms are described as a microbial population attached to a substrate, surrounded by a self-
derived extracellular matrix. This mode of life presents important clinical repercussions since it
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is estimated that over half of all hospital infections are originated from these microbial commu-
nities [1]. The relevance of this is that biofilm cells are phenotypically distinct from their ‘free-
living’ or planktonic forms, exhibiting elevated resistance to host defenses and higher tolerance
to antimicrobial agents [2]. Besides the colonization of the oral mucosal surfaces, biofilms can
develop on abiotic substrates, including the internal surfaces of dentures [2,3]. Therefore, bio-
films act as reservoirs of pathogenic microorganisms [3–5] favoring the dissemination of infec-
tion to other body sites [6,7]. Synergistic, mutualistic, and antagonistic interactions that occur
between microorganisms contribute to the development of polymicrobial biofilm communities
[8,9]. Currently, the Staphylococcus aureus and Candida species are ranked among the top
three bloodstream pathogens causing severe morbidity and mortality in hospitalized patients
[4,10]. Besides the fact that Candida albicans and S. aureus are responsible for a substantial
number of infections independently, there is increasing evidence that they can be commonly
associated as co-infector microorganisms [5,11–14]. The clinical outcome of these mixed bac-
terial-fungal interactions is that the infections can correlate with increased frequency or severi-
ty of disease [11,15,16]. Infections due to polymicrobial biofilms have also been related to
significantly higher mortality rates (70%) when compared to infections caused by a single spe-
cies of microorganism (23%) [17].
C. albicans is a commensal colonizer of oral mucous membranes that can become an oppor-
tunistic pathogen and is considered the most prevalent [3] and virulent [18] of the Candida
species. Despite its high virulence as a single pathogen, it has been estimated that about 27% of
patients with candidemia had polymicrobial blood cultures, with S. aureus as the third most
common organism isolated in conjunction with C. albicans [19]. S. aureusmethicilin-resistant
(MRSA) has also been recognized as one of the most virulent human pathogens, especially due
to its ability to develop resistance against several drug therapies [20,21] and to form biofilms
[14,22,23]. In fact, approximately 52% of nosocomial infections in patients in intensive care
units are due to MRSA [24], which is responsible for severe infections, such as aspiration pneu-
monia [25,26].
There is increasing evidence in the literature regarding the importance of polymicrobial in-
fections and some studies have focused on the interactions between the eukaryotic pathogen C.
albicans and the prokaryotic pathogen S. aureus [5,11–14]. At the moment, it is known that the
synergy between these pathogens in a biofilm results in a stronger biofilm formation with in-
creased antimicrobial tolerance [5,12]. In addition, higher mortality rates in mice co-infected
with sublethal levels of these microorganisms have been observed [11]. Despite of these studies,
some gaps in the virulence attributes of these microorganisms in biofilms still remain to be in-
vestigated. In polymicrobial communities, the effect of these specific virulence factors may be
influential and perhaps potentiate the pathogenicity of these biofilms. Among these virulence
factors, the secretion of specific degradative enzymes can be highlighted as one of the most sig-
nificant, since they are involved in colonization and infection processes [27,28]. To the author’s
knowledge, the quantification of some hydrolytic enzymes in polymicrobial biofilms has not
yet been conducted. Despite the fact that C. albicans and S. aureus are often co-isolated in cases
of biofilm associated infections [29], literature on the interactions between these pathogens is
limited and should be further explored in a more comprehensive way. Thus, the aim of the
present study was to investigate the dynamic interaction between C. albicans and methicillin-
susceptible (MSSA) and-resistant S. aureus (MRSA) in terms of characterization of the viable
cells, metabolic activity, and total biomass of biofilms. In addition, the quantification of the ex-
tracellular hydrolytic enzymes aspartyl proteinase (SAP) and phospholipase C (PL-C) in these
biofilms using a highly sensitive fluorimetric method was evaluated.
Characterization of C. albicans and S. aureusDual Biofilms
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Material and Methods
Strains and growth conditions
Three reference strains were used in this study. Candida albicans wild-type strain from the
Spain Collection (SC5314), a human clinical isolate, was selected based on its high ability to
grow in the invasive hyphal form [30,31]. Two reference Staphylococcus aureus from the Amer-
ican Type Culture Collection Methicillin-susceptible Staphylococcus aureus (MSSA—ATCC
25923) and methicillin-resistant S. aureus (MRSA—ATCC 33591) strains were selected be-
cause they are capable of biofilm formation in vitro [32,33]. In addition, these strains were also
used in other investigations where the interaction of Candida-Staphylococcus biofilms was eval-
uated [5,12–14].
C. albicans was maintained in Yeast Peptone Glucose medium (YEPD: 1% yeast extract, 2%
Bacto peptone and 2% D-glucose, 2% agar) and frozen at -70°C until use. The microorganism
was subcultured onto Sabouraud Dextrose Agar plates (SDA—Acumedia Manufactures Inc.,
Baltimore, MD, USA) [34] supplemented with chloramphenicol (0.05 g L-1) and incubated at
37°C for 24–48 h to generate the C. albicans yeast used for all the experiments.
Bacteria strains were maintained in Tryptic Soy Broth medium (TSB—Acumedia Manufac-
tures Inc., Baltimore, MD, USA) [33] and frozen at -70°C until use. The microorganisms were
subcultured onto Mannitol Salt Agar plates (Acumedia Manufactures Inc., Baltimore, MD, USA)
[33] and incubated at 37°C for 24–48 h to generate the bacteria cells used for the experiments.
To prepare the yeast and bacteria inocula, a loop full of the agar stock cultures was trans-
ferred to 5 mL of Yeast Nitrogen Base broth (YNB—Difco, Becton Dickinson Sparks, MD,
USA) supplemented with 100 mM glucose and TSB, respectively, and incubated at 37°C over-
night in an orbital shaker (75 rpm). Cells of the resultant cultures were harvested and washed
twice with phosphate-buffered saline solution (PBS, pH 7.2) at 5,000 x g for 5 min (rotor
model A462). Washed microorganisms were re-suspended in RPMI 1640 (Sigma-Aldrich,
St. Louis, MO, USA). Both Candida and Staphylococcus suspensions were spectrophotometri-
cally standardized at an OD540 nm of 1.0 and OD600nm of 0.1, respectively, which corre-
sponds to a final concentration of 107 cells per mL-1 [14].
Adhesion and biofilm formation
Single species adhesion and biofilms assays were carried out on 96-well microplates (Orange
Scientific, Belgium) containing 75 μL of RPMI 1640 and 75 μL of each cellular suspension.
Dual species adhesion and biofilm formation were also performed in 96-well microplates con-
taining 75 μL of the suspension of each microorganism used in the following associations: C.
albicans + MSSA and C. albicans + MRSA. For the adhesion assays, culture plates were incu-
bated at 37°C in an orbital shaker (75 rpm) for 90 min. For the biofilm formation, the plates
were also incubated for 90 min at 37°C in an orbital shaker (75 rpm). The non-adherent cells
were then removed by gently washing twice with 150 μL PBS and 150 μL of fresh RPMI 1640,
added to each well. The plates were incubated for 12 h, 24 h, and 48 h. In the case of the 48 h
biofilms, 75 μL of the suspensions were removed and an equal volume of fresh RPMI 1640 was
added after the first 24 h.
Quantification of adhered and biofilm cells
The number of adhered cells and those present in the biofilms was determined by counting col-
ony-forming units (CFUs). The wells were briefly washed twice with PBS to remove loosely at-
tached cells and resuspended in 100 μL of PBS. Next, the adhered biofilm was carefully scraped
off the wells with a sterile pipette tip for 1 min [35]. Cristal violet (CV) staining as described
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below was used to confirm the complete removal of the adhered cells and biofilms. The 100 μL
suspensions were then vigorously vortexed to separate a possible aggregation among the cells.
Serial decimal dilutions (in PBS) were made and the number of C. albicans was determined by
pipeting replicate specimens (25 μL) of the suspensions on SDAmedium supplemented with
chloramphenicol. The same procedures were performed for the MSSA/MRSA cells, which were
plated on Mannitol Salt Agar [10,33]. For the dual species studies, serial dilutions were plated
onto both media. The plates were incubated for 24h-48 h at 37°C and the values of CFU mL-1
were counted. The experiments were performed in five replicates and repeated in three
independent assays.
Quantification of metabolic mitochondrial activity
The total metabolic activity of adherent and biofilm cells was measured through the 2,3-bis re-
duction assay (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazo-
liumhydroxide (XTT) using a previous described method [36]. After 90 min of adhesion and
12 h, 24 h, and 48 h of biofilm formation, the XTT (Sigma) was prepared in ultrapure water at
a final concentration of 1 mg mL-1. The solution was filter sterilized and stored at -70°C until
use. The menadione solution (Sigma) was prepared in acetone at 0.4 mM immediately before
each assay. The wells of a 96-well tissue plate were washed with 150 μL of PBS (0.1 M, pH 7)
and a mixture of 158 μL YNB with 200 mM glucose, 40 μL XTT, and 2 μL menadione was
added to each well. The plates were incubated at 37°C for 3 h in the dark and the absorbance at
492 nm was then read in an ELISA plate reader in the 96-well tissue plates. The experiments
were performed in five replicates and repeated in three independent assays.
Quantification of total biofilm biomass
Total biofilm biomass was measured using a CV staining method as described before [36].
Briefly, after 12h, 24h, and 48 h of biofilm formation, the medium was totally aspirated and the
non-adherent cells removed by washing the wells with 150 μL of PBS. The single and dual-spe-
cies biofilms were then fixed with 200 μL of 100% (v/v) methanol, which was removed after 15
min. The culture plates were allowed to dry at room temperature and 200 μL of CV (1% v/v)
was then added to each well and incubated for 5 min. The wells were gently washed twice with
150 μL of PBS and 200 μL of acetic acid (33% v/v) was added to release and dissolve the stain.
Optical density (Absorbance) of the eluted solution was read in a microtiter plate reader (Bio-
Tek Synergy HT, Izasa) at 570 nm. The experiments were performed in five replicates and re-
peated in three independent assays.
Quantification of extracellular hydrolytic enzymes
The supernatants of the 48 h single- and dual-species biofilms were centrifuged for 5 min at
5,000 rpm to remove any cells and evaluated for secreted aspartyl proteinase (SAP) activity
using the fluorimetric EnzChek Protease Assay kit for green fluorescence (Molecular Probe,
Inc., Eugene, OR, USA), according to the manufacturer's recommendations. Briefly, 0.2 mL of
the BODIPY FL casein stock solution (1.0 mg mL-1) and 19.8 mL of the digestion buffer (dilut-
ed 1:20) were prepared and mixed. Thereafter, 100 μL of the working solution were added to
100 μL of the centrifuged supernatants in black 96-well microplates for fluorescence detection
(Greiner Bio ONE, Frickenhausen, Germany) and the plates were incubated for 2 h at room
temperature, protected from light. The fluorescence was read in a fluorescence microplate
reader (Fluoroskan Ascent microplate fluorometer, USA) at 485 nm of excitation and 538 nm
of emission. The fluorescence values were used in linear equations derived from the previously
obtained standard curves and the enzymatic activity was expressed in μg mL-1.
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For the phospholipase C (PL-C) assay, the 48 h single- and dual-species biofilms were resus-
pended in a lysis buffer (2 M Tris- HCI, 1 M CaCl2, ultra-purified water, pH 7.4), sonicated for
20 seconds to disrupt the biofilms, and centrifuged for 5 min at 10,000 rpm. To evaluate the
PL-C activity, the Amplex Red phosphatidylcholine-specific phospholipase C assay kit (Molec-
ular Probe, Inc., Eugene, OR, USA) was used, according to the manufacturer's recommenda-
tions. Briefly, a working solution was prepared mixing 200 μL of Amplex Red reagent stock
solution (20 mM), 100 μL of horseradish peroxidase stock solution, 200 μL of alkaline phos-
phatase stock solution, 100 μL of choline oxidase stock solution, and 78 μL of the lecithin solu-
tion to 9.32 mL of Reaction Buffer (1:5). The assays were performed in black 96-well
microplates, in a total volume of 200 μL per well (100 μL of the product of the centrifugation of
the biofilms and 100 μL of the working solution). The plates were then incubated for 3 h at
37°C, protected from light. The fluorescence was read in a fluorescence microplate reader at
544 nm of excitation and 590 nm of emission. The fluorescence values (nm) were recorded and
used for comparisons in relation to the fluorescence values of the positive controls provided by
the manufacturer [purified PL-C from Bacillus cereus and Hydrogen Peroxide (H2O2)].
For both enzymes, all tests were performed on three separate occasions, with four samples
in triplicate for each experimental condition.
Scanning electron microscopy
Scanning electron microscopy (SEM) was used to examine the biofilm structures and the inter-
actions between the Candida and Staphylococcus cells. For this assay, single- and dual-species
biofilms were formed on polystyrene disks cut to loosely fit in the 24-well microplates (Orange
Scientific, Belgium). Thus, after 90 min, 12h, 24h, and 48 h of incubation, the medium was as-
pirated and the non-adherent cells removed by washing twice with 1 mL of PBS. The discs
were then dehydrated with an ethanol series (70% ethanol for 10 min, 95% ethanol for 10 min
and 100% ethanol for 20 min) and air dried for 20 min. Disc samples were kept in a desiccator
before analysis. Prior to observation, the discs were mounted onto aluminum stubs sputter
coated with gold and observed using a Hitachi Tablelap Scanning Electron Microscope TM-
3000 (Tokyo, Japan).
Statistical analysis
The results of the CFU, CV, and XTT reduction values were compared using two-way ANOVA
with the Tukey post-hoc test. The two factors considered were growth condition (C. albicans,
MSSA, MRSA, C. albicans +MSSA, and C. albicans +MRSA) and time period (90 min, 12h,
24h, and 48h for the CFUmL-1 and XTT assays, and 12h, 24h, and 48h for the CV assay).
For the SAP and PL-C activities, only the growth factor condition was analyzed using one-
way ANOVA (Welch ANOVA in cases of unequal variance) followed by the Games-Howell
post hoc test.
All tests were performed using the SPSS statistical software package (SPSS Inc., Chicago,
USA) with a confidential level of 95%.
Results
Quantification of adhered and biofilm cells
Table 1 shows the summary of the ANOVAs for all virulence factors analyzed. C. albicans,
MSSA and MRSA were able to adhere (90 min) and to form biofilms either in single state or in
mixed cultures. Table 1 shows that the time period factor had a significant effect (p<0.0001)
on the log10 CFU mL
-1 values of C. albicans. Fig 1A shows a small but gradual increase in the
Characterization of C. albicans and S. aureusDual Biofilms
PLOS ONE | DOI:10.1371/journal.pone.0123206 April 13, 2015 5 / 15
log10 CFU mL
-1 values over time and, at 48 h, the number of cells of all growth conditions was
significantly higher than in the other time periods (ρ<0.05).
For the bacteria, both factors analyzed had a significant effect (ρ<0.0001) on the log10 CFUmL
-1
values (Table 1). Regardless of whether they were grown as single- or dual-species biofilms, there
was a gradual increase in the log10 CFUmL
-1 values over time (Fig 1B), reaching the peak values at
48 h (ρ<0.05). It was also observed that the number of MSSA cells increased significantly (ρ<0.05)
when cultured in the presence of C. albicans at 48 h (Fig 1B).
Table 1. ANOVAs for mean values of log10 CFUmL
-1, Abs CV, Abs XTT, SAP activity, and PL-C activity forC. albicans and bacteria results.
DF† F-value ρ-value
log10CFU mL
-1 C. albicans Period of time 3 56.5166 <0.0001*
Growth condition 2 0.7846 0.5381
Interaction 6 1.5518 0.1635
Bacteria Period of time 3 337.5055 <0.0001*
(MSSA/MRSA) Growth condition 3 15.1278 <0.0001*
Interaction 9 4.1278 0.0002*
Abs CV Period of time 2 44.7022 <0.0001*
Growth condition 4 206.437 <0.0001*
Interaction 8 3.7525 0.0006*
Abs XTT Period of time 3 268.3263 <0.0001*
Growth condition 4 187.3755 <0.0001*
Interaction 12 21.2554 <0.0001*
SAP activity Growth condition 3 326.653 <0.0001*
PL-C activity Growth condition 6 82.697 <0.0001*
†DF: Degrees of Freedom.
*Signiﬁcant differences at ρ<0.05.
doi:10.1371/journal.pone.0123206.t001
Fig 1. Mean log10 CFUmL
-1 values for grown of C. albicans (A), MSSA and MRSA (B) as single- and dual-species grown in RPMI at 37°C. Error bars
represent standard deviation. The uppercase letters show differences among time periods and lowercase letters show differences among the growth
conditions (Tukey post-hoc test at ρ>0.05).
doi:10.1371/journal.pone.0123206.g001
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Quantification of metabolic mitochondrial activity
Two-way ANOVA revealed significant effects for the time period and growth condition for the
Abs XTT values (Table 1). Except for the MRSA single biofilms, that showed higher metabolic
mitochondrial activity at 48 h, all microorganisms in both growth conditions had a significant
increase (ρ<0.05) in the biofilm metabolic activity from the adhesion period to 12 h of biofilm
formation, after which no changes were observed (Fig 2).
When the growth condition factor was analyzed, from the adhesion phase to the 24 h bio-
film formation, there were no significant differences (ρ>0.05) in the metabolic activity between
the single and dual cultures with C. albicans, which had higher values of Abs XTT (ρ<0.05)
than the single bacteria cultures. At 12 h and 24 h of biofilm growth, the MRSA single-species
biofilm presented significantly lower values (ρ<0.05) of metabolic activity than the MSSA. At
48 h of biofilm formation, there were no significant differences (ρ>0.05) among single- and
dual-species biofilms, with the exception of the C. albicans biofilm, which presented higher
metabolic activity than that of the MRSA (ρ<0.05).
Quantification of total biofilm biomass
Two-way ANOVA revealed significant effects for the time period and growth conditions for
the Abs CV values (Table 1). Fig 3 presents the results for total biomass of single and dual
Fig 2. Absorbance values of XTT reduction (Abs XTT) obtained from 90 min of adhesion and biofilms of C. albicans, MSSA, andMRSA as single-
and dual-species grown in RPMI at 37°C. Error bars represent standard deviation. The uppercase letters show differences among time periods and
lowercase letters show differences among the growth conditions (Tukey post-hoc test at ρ>0.05).
doi:10.1371/journal.pone.0123206.g002
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biofilms of C. albicans, MSSA and MRSA. Generally, C. albicans single and mixed biofilms had
significantly higher total biomass values (ρ<0.05) than the single biofilms of bacteria. Except
for the significant increase in total biomass of the single MRSA biofilm at 24 h, all growth con-
ditions showed no changes from 12 h to 24 h biofilm formation (ρ>0.05). While both mixed
biofilms increased the total biomass from 24 h to 48 h (ρ<0.05), no significant change was ob-
served for the C. albicans single biofilm.
Quantification of extracellular hydrolytic enzymes
One-wayWelch ANOVA revealed significant effects of growth condition in the SAP and PL-C
activities (Table 1). For the SAP activity, the single biofilm of C. albicans and the mixed biofilm
of C. albicans plus the MRSA produced significant lower amounts (ρ<0.001) of SAP when com-
pared to the single biofilm of MSSA and the mixed biofilm of C. albicans plus MSSA (Fig 4A).
The enzymatic activity of the single biofilm of MRSA was not detected using the fluorimetric kit.
The fluorimetric values for PL-C activity are presented in Fig 4B. C. albicans single and mixed
biofilms had significantly higher fluorimetric values (ρ<0.05) than the single biofilms of bacte-
ria. Both positive controls showed higher fluorimetric values (ρ<0.05) than C. albicans, MSSA,
and MRSA in all growth conditions.
Fig 3. Absorbance values of CV solutions (Abs CV) obtained from biofilms of C. albicans, MSSA, and MRSA as single- and dual-species grown in
RPMI at 37°C. Error bars represent standard deviation. The uppercase letters show differences among time periods and lowercase letters show differences
among the growth conditions (Tukey post-hoc test at ρ>0.05).
doi:10.1371/journal.pone.0123206.g003
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Scanning electron microscopy
Scanning electron microscopy was used to examine the single and dual adhered and biofilm
species in terms of structure and interactions between the candidal and bacteria cells (Fig 5).
The single C. albicans showed, at 90 min, a non-contiguous layer of cells, which presented
an initial formation of hyphal forms, and evolved into mature biofilm producing a thickness of
co-aggregated cells with a higher number of hyphae at 12 h, 24 h, and 48 h. It is important to
emphasize that the 48 h biofilm formation resulted in a more robust biofilm (Fig 5). The single
MSSA and MRSA, at the initial phase of 90 min, revealed a similar extent of adhesion with
lower quantity of uniformly distributed cells. The structure of both biofilm strains was compa-
rable, despite that the MSSA biofilms presented a higher number of intimately packed cocci
(Fig 5).
Fig 5 also represents the dual species physical interactions. Images revealed extensive adher-
ence of MSSA and MRSA to C. albicans, with a preferential association to the hyphal elements
of C. albicans and to a lesser degree, the round yeast cells. In fact, after 90 min of interaction,
the bacteria cells were able to interact with the C. albicans cells. In addition, it is important to
highlight that in areas of dense hyphal biofilm growth, the MSSA and MRSA cells appear in
higher quantity than in the well surface.
Discussion
In the present study, the CFU, XTT, and crystal violet assays were used to evaluate the interac-
tions of single and dual biofilms because these methodologies are complementary. The crystal
violet biomass assay quantifies the matrix of both living and dead cells. Because all cells and
matrix are stained in this method, it provides the general condition of the biofilm. However,
neither the viable cells of the biofilm nor their metabolic activity is evaluated. To discriminate
between living and dead cells, the CFU method was chosen because it is the widely gold stan-
dard method used. Its noteworthy advantage is that only the viable cells are counted, excluding
the dead ones and debris. However, this method quantifies all viable cells, including those with
low metabolic activity. Thus, another quantification method based on the metabolic activity
(XTT) was used in the present study. For all methodologies, the biofilm formation was stopped
at 48 h because the biofilms are sufficiently mature at this time point [2,37,38]. In addition, this
Fig 4. SAP (A) and PL-C (B) activities of biofilms of C. albicans, MSSA, andMRSA, as single- and dual-species grown in RPMI at 37°C, and the
positive controls. Error bars represent standard deviation. The uppercase letters show differences among the growth conditions (Games-Howell post-hoc
test at ρ>0.05).
doi:10.1371/journal.pone.0123206.g004
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protocol of biofilm formation has already been adopted by other studies that evaluated single
and dual biofilms [9,13].
The results of the present investigation showed that all three pathogenic microorganisms
were able to adhere in a similar extent, with no apparent antagonism (Fig 1). This initial attach-
ment of cells was followed by cell division, proliferation, and biofilm development. The current
study also demonstrated that, under the conditions tested, all strains were able to form bio-
films, although in different extents (Figs 1, 2, 3, and 5). Indeed, it was not observed that the bac-
teria’s number decreased over time in the presence of C. albicans, indicating the ability of the
yeasts and bacteria to co-inhabit. C. albicans levels in single- and dual-biofilms were not differ-
ent (Fig 1 A). It is important to emphasize that, in the presence of C. albicans, the number of
bacteria cells increased in specific periods of time comparatively to its single biofilms (Fig 1 B).
Similar results were also observed by Harriott & Noverr [5], who monitored fungal and bacteri-
al growth within biofilms and observed that while the C. albicans levels presented no changes
in the single- and dual-biofilms, the S. aureus levels were significantly increased in the dual bio-
films. A possible explanation for this phenomenon could be the presence of higher quantity of
glucose, a major component of the C. albicansmatrix [39]. In fact, glucose can provide a car-
bon source for S. aureus growth and increase its biofilm formation [5].
Considering the metabolic activity assay, it was observed that, from the adhesion phase
until the earlier biofilm formation at 24 h, the metabolic activity of single and dual cultures
with C. albicans were higher than the single bacteria, as expected. In fact, single MSSA and
Fig 5. Scanning electronmicroscopy of adhered single- and dual-species (90 min) and biofilms (12 h, 24 h, and 48 h) of C. albicans, MSSA, and
MRSA in RPMI at 37°C. The bar in images corresponds to 20 μm for C. albicans (magnification of x2500) and 20 μm for bacteria and mixed growth
(magnification of x5000).
doi:10.1371/journal.pone.0123206.g005
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MRSA biofilms only achieved similar metabolic activity values at the 48 h period. Since biofilm
cells are organized into structured communities embedded within an extracellular matrix, ac-
tivity within biofilms would be dependent on nutrient access and availability of oxygen, togeth-
er with removal of waste products [35]. These factors may vary because of inherent differences
in the biofilms produced by the different microorganisms tested here, resulting in variations in
biofilm metabolic activity. In addition, in the present study, RPMI media was used for biofilm
formation because, according to the literature [40], it induces hyphal development. This may
have influenced the metabolic results due to the lack of some nutrients for both microorgan-
isms. From Fig 3, it can be seen that both the C. albicans and dual species biofilms produced
higher biofilm biomass than the bacteria monomicrobial biofilms. Bamford et al. [41], who in-
vestigated a biofilm formed by Streptococcus gordonii and C. albicans, also noted that complex
physical and chemical interactions between microorganisms resulted in an increased biomass
of co-inoculated biofilms. More recently, a similar interaction pattern has been reported for C.
albicans and MRSA [42].
It is important to highlight that a direct comparison of total biofilm biomass and metabolic
activity may mislead, since there are significant differences between bacteria and yeasts, includ-
ing relative cell size, morphology, and biochemistry. Despite the fact that the literature is sparse
on the effects of microbial interaction on metabolic activity, our results are corroborated by a
recent study, in which dual biofilms of C. albicans and S. aureus showed higher metabolic activ-
ity than the single bacteria biofilms [13]. This result is important given the fact that biofilm ac-
tivity is significant in terms of pathogenicity since it is a likely indicator of growth, production
of hydrolytic enzymes and, in the case of reduced activity, of possible resistance to antimicrobi-
al activity [35]. The ability of these two organisms to maintain the growth and metabolic activi-
ty when they are together may have potential clinical implications for polymicrobial infections.
In fact, in vivo studies demonstrated that mice inoculated with S. aureus showed low mortality,
whereas the co-inoculation with C. albicans resulted in a higher rate of mortality [11,42]. A re-
cent study also found that co-infection with these microorganisms led to a 40% mortality rate
and increased microbial burden in the spleen and kidney by day 1 post-infection [42]. Thus,
the interaction between these two organisms appears to be beneficial to each other.
According to the authors’ knowledge, there is a lack of studies evaluating the secretion of
degradative enzymes by dual biofilms of C. albicans and S. aureus. When compared to other
virulence attributes, the secretion of SAP and PL-C has a more pronounced influence on the
pathogenicity of the microorganisms. Lyon et al. [43] found a positive correlation between
higher SAP and PL-C production and greater adhesion to buccal cells and resistance to flucon-
azole of C. albicans isolates. In addition, there is evidence showing that biofilm formation is
also positively associated with secretion of hydrolytic enzymes [44]. In the present study, for
single biofilms, S. aureus showed higher SAP activity when compared to C. albicans, which in
turn produced higher PL-C activity. Interestingly, when the microorganisms were in a co-cul-
ture, both enzymes were also produced (Fig 4), which suggests an increased pathogenicity of
dual biofilms. Kaminishi and colleagues [45] reported that the SAP produced by C. albicans ap-
pears to reduce opsonization and phagocytosis of S. aureus by polymorphonuclear leukocytes,
so that the breakdown of the humoral host defense mechanisms caused by the action of C. albi-
cans SAP can leave the hosts more vulnerable to microbial infections and aggravate infectious
diseases in compromised hosts. In addition, the secretion of SAP by Staphylococcus could help
C. albicans to enhance its adhesion to the mucosal layer [46]. The specific roles of these two hy-
drolytic enzymes in colonization and infection processes are slightly different. In general, SAPs
induce the degradation of a large variety of host proteins, increasing the ability of microorgan-
isms to colonize and invade host tissues [47]. SAPs are also able to break down portions of im-
munoglobulins, which are glycoproteins synthesized and secreted by plasma cells that function
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as antibodies. This mechanism plays a major role in disrupting the humoral host defense
[45,48]. The extracellular PLs are capable to target and digest the membrane phospholipids,
the major component of all host cell membranes, thereby facilitating microorganism invasion
[49]. Since PLs are concentrated mostly in the tips of the hyphae, such host cell injury would be
expected to facilitate the penetration of the infecting microorganisms [50]. In addition, PLs
have been found to be a potent inflammatory agent, inducing the accumulation of inflammato-
ry cells and plasma proteins and release of various inflammatory mediators in vivo [50]. The
fluorimetry methods used in the present study were not able to detect the secretion of SAP by
the single biofilm of MRSA. This method is considered more sensitive than the colorimetric’s
[27,51–53] and those based on the formation of an opaque degradation halo in specific agar
plates [28,54–57]. In addition, the fluorimetry assays are considered suitable for research in-
volving biofilms [53] and strains with low levels of enzymatic activity [50,56].
The present investigation also showed that extensive interactions did occur between C. albi-
cans and the bacteria growing in mixed biofilms and, in general, C. albicans favors bacterial
growth. SEM images revealed an extensive adherence of MSSA and MRSA to C. albicans, with
a preferential association to the invasive hyphal elements of C. albicans. In areas of dense hy-
phal biofilm growth, the S. aureus cells could be seen completely covering the C. albicans hy-
phae (Fig 5). Peters et al. [14] also observed an association between S. aureus cells and invasive
hyphal forms of C. albicans, but not the round yeast cells. This interaction was further elucidat-
ed by these authors, who observed that S. aureus binds to C. albicans agglutinin-like sequence 3
(als3), which plays a key role in mediating the adherence of bacteria cells to C. albicans hyphae
[23]. Because S. aureus preferentially associates with the hyphae, Harriott and Noverr [12] sug-
gested that dual biofilm formation is initiated after C. albicans adheres to a substrate surface,
which initiates germination. Attachment of S. aureus to the germinating hyphae would pre-
sumably occur at the substrate surface and continued growth of both species occurs concomi-
tantly. This observation is supported by previous studies that showed that S. aureus was found
throughout the depth of the dual biofilm with microcolonies on the surface [5,12,23]. More-
over, it has been demonstrated that, when S. aureus was associated with the hyphal forms, it
was surrounded with a distinct halo of matrix material secreted by C. albicans. As a result, S.
aureus resistance to vancomycin was increased, probably due to the matrix that may limit pen-
etration of the drug into the biofilm [5].
Mono or polymicrobial infections are complex processes regulated by a dynamic equilibri-
um among the host immune defense, microorganisms’ interaction and their virulence factors.
This study demonstrated that C. albicans, MSSA, and MRSA can co-exist in a biofilm mode of
growth, in an apparent synergistic effect, with bacteria cells preferentially associated to hyphal
forms. In general, the dual biofilms showed an evolutive behavior over time in terms of number
of cells, metabolic activity, and total biomass. Furthermore, when C. albicans, MSSA, and
MRSA were in a co-culture, both SAP and PL-C enzymes were produced, which may suggest
an increased severity of dual biofilms. Although it is unlikely that the specific resistance mecha-
nisms to antibiotics of MRSA (presence of mecA gene) would influence the Candida-bacteria
interactions, it is important to highlight that other factors determining the difference between
MRSA and MSSA strains must exist, and should be further investigated, excluding differences
in drug resistance mechanisms. In fact, our results showed some significant differences be-
tween bacteria biofilms and their combination with C. albicans. This indicates that, despite
both bacterial populations are virulent, the mechanisms of pathogenesis of MRSA and MSSA
infections may differ at some degree. With that in mind, this study contributed to the under-
standing of the complex interactions between microbial species, which would provide a new
perspective for developing new strategies for the prevention, control and treatment of polymi-
crobial infections. The identification of potential targets for the inhibition of co-adhesion,
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biofilm development, and enzymes secretion may ultimately provide the means to modify mi-
crobial colonization and infection, reducing the impact of polymicrobial diseases on human
health.
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